** Shares of med-tech firm Predictive Oncology Inc POAI.O
down 22.8% at $0.21 premarket
** Company announces a reverse stock split of its common
stock at a ratio of 1 post-split share for every 20 pre-split
shares, effective Monday
** Reverse stock split primarily intended to bring company
into compliance with Nasdaq bid price requirement and avoid
delisting - POAI
** The move will reduce the outstanding shares to ~3,979,860
from 79,597,181 shares, says company
** As of last close, stock down ~10% YTD
(Reporting by Richard Rohan Francis in Bengaluru)
((RichardRohan.Francis@thomsonreuters.com;))